Skip to content

Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00918528
Enrollment
Unknown
Registered
2009-06-11
Start date
2009-06-30
Completion date
Unknown
Last updated
2009-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urethral Stricture

Keywords

Urethral stricture, Mitomycin C, Internal Urethrotomy

Brief summary

The aim of this study is to evaluate the efficacy of local injected mitomycin C at the time of internal urethrotomy in order to prevent the recurrence of urethral strictures.

Interventions

DRUGMitomycin C - local injection

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Male urethral stricture suitable for internal urethrotomy * Stricture length less than 10 mm

Exclusion criteria

* Stricture length over 10 mm * Benign prostate enlargement

Design outcomes

Primary

MeasureTime frame
Urethral stricture recurrenceOne year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026